Bollard Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,121
| Closed | -$5K | – | 327 |
|
|
2022
Q1 | $5K | Hold |
1,121
| – | – | ﹤0.01% | 418 |
|
|
2021
Q4 | $6K | Hold |
1,121
| – | – | ﹤0.01% | 421 |
|
|
2021
Q3 | $14K | Hold |
1,121
| – | – | ﹤0.01% | 401 |
|
|
2021
Q2 | $24K | Hold |
1,121
| – | – | ﹤0.01% | 389 |
|
|
2021
Q1 | $31K | Hold |
1,121
| – | – | ﹤0.01% | 374 |
|
|
2020
Q4 | $29K | Hold |
1,121
| – | – | ﹤0.01% | 376 |
|
|
2020
Q3 | $42K | Hold |
1,121
| – | – | ﹤0.01% | 334 |
|
|
2020
Q2 | $58K | Buy |
+1,121
| New | +$58K | ﹤0.01% | 326 |
|